CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,906
- in 7 filings
Net −$417,906. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-11 | Stevens Christopher James Chief Operating Officer | Sale | −36,658 | $3.50 | $128K | 505,784 |
| 2026-08-03 | Stevens Christopher James Chief Operating Officer | Grant or award | +73,313 | 542,442 | ||
| 2026-08-03 | Stevens Christopher James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +101,428 | 101,428 | ||
| 2026-02-11 | Stevens Christopher James Chief Operating Officer | Grant or award | +61,963 | 469,129 | ||
| 2026-02-11 | Stevens Christopher James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +93,037 | 93,037 | ||
| 2025-08-04 | Stevens Christopher James Chief Operating Officer | Grant or award | +407,166 | 407,166 | ||
| 2025-08-04 | Stevens Christopher James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +554,071 | 554,071 |
Page 1 of 1 · 7 trades